IMARC Group, a leading market research company, has recently releases report titled “Neurovascular Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global Neurovascular Devices market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
How Big Is The Neurovascular Devices Market?
The global neurovascular devices market size reached US$ 2.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.9 Billion by 2028, exhibiting a growth rate (CAGR) of 5.9% during 2023-2028.
What are Neurovascular Devices?
Neurovascular devices, also known as interventional neurology machines, are used to treat various disorders, such as stenosis, arteriovenous malformation, ischemic stroke aneurysms, and fistulas. They include liquid embolic agents, flow diversion devices, embolic coils, arterial stents, catheters, and guidewires. Neurovascular devices use minimally invasive and image-guided techniques to treat hazardous and complicated conditions of the neck and spine. In addition to this, these machines allow physicians to gain endovascular access to the treatment areas in the brain and provide efficient therapy. As a result, neurovascular devices are gaining immense traction in the healthcare industry and are extensively utilized in the diagnosis and treatment of several peripheral and central nervous system disorders.
Request For A Free Sample Copy Of This Report:https://www.imarcgroup.com/neurovascular-devices-market/requestsample
What Are The Growth Prospects And Trends In The Neurovascular Devices Industry?
The increasing geriatric population across the globe, that is highly susceptible to acquiring chronic disorders, is among the primary factors driving the neurovascular devices market. Besides this, the rising cases of strokes, cerebral hemorrhage, and obesity, owing to the emerging trend of urbanization, sedentary lifestyles, and stress, are further augmenting the market growth. Moreover, continuous technological advancements in neaurovascular treatments and the launch of various policies by the government bodies to modernize the healthcare infrastructure are also catalyzing the global market. Apart from this, the growing awareness among patients toward the easy availability of treatment and reimbursement for these disorders is propelling the usage of these devices, which is acting as another significant growth-inducing factor. Additionally, the quick expansion of ambulatory care centers, research laboratories, hospitals, surgical epicenters, and academic institutes is also stimulating the market growth. Furthermore, the escalating focus of the leading players on broadening the range of these tools for treating certain types of aneurysms with excellent safety and efficacy is anticipated to propel the neurovascular devices market over the forecasted period.
What Is Included In Market Segmentation?
The report has segmented the market into the following categories:
Breakup by Product:
Cerebral Embolization and Aneurysm Coiling Devices
- Embolic Coils
- Flow Diverters
- Liquid Embolic Agents
Cerebral Angioplasty and Stenting Systems
- Carotid Artery Stents
- Embolic Protection Devices
Neurothrombectomy Devices
- Clot Retrieval Devices
- Suction Devices
- Vascular Snares
Support Devices
- Micro Catheters
- Micro Guidewires
Breakup by Application:
- Ischemic Stroke
- Aneurysm
- Arteriovenous Malformation and Fistulas (AVM)
- Stenosis
- Others
Breakup by End User:
- Hospitals
- Ambulatory Surgical Centers
- Clinics
Market Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Who Are The Key Players Operating In The Industry?
The report covers the major market players including:
- Acandis GmbH
- Asahi Intecc Co. Ltd.
- Imperative Care Inc.
- Integer Holdings Corporation
- Johnson Johnson
- Medtronic plc
- MicroPort Scientific Corporation
- Penumbra Inc.
- Perflow Medical Ltd.
- Rapid Medical
- Stryker Corporation
- and Terumo Corporation.
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Email: sales@imarcgroup.com
Follow us on Twitter: @imarcglobal
LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/
